A-ALPHA BIO
A-Alpha Bio provides cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library screening, and preclinical drug characterization. A-Alpha Bio's product, AlphaSeq, is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured. A-Alpha Bio is a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck.
A-ALPHA BIO
Industry:
Biotechnology Health Care Product Design
Founded:
2017-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.aalphabio.com
Total Employee:
11+
Status:
Active
Contact:
8584057116
Total Funding:
24.45 M USD
Technology used in webpage:
Euro Wix Google Cloud Global Multi-Region Wix Hosted
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Advisors List
Board_member
2021-01-01
Board_member
2021-01-01
Current Employees Featured
Randolph Lopez Co-founder and CTO @ A-Alpha Bio
Co-founder and CTO
2018-01-01
David Younger CEO @ A-Alpha Bio
CEO
Founder
Investors List
Madrona Venture Group
Madrona Venture Group investment in Series A - A-Alpha Bio
Perceptive Advisors
Perceptive Advisors investment in Series A - A-Alpha Bio
Lux Capital
Lux Capital investment in Series A - A-Alpha Bio
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - A-Alpha Bio
National Science Foundation
National Science Foundation investment in Grant - A-Alpha Bio
Madrona Venture Group
Madrona Venture Group investment in Seed Round - A-Alpha Bio
Sahsen Ventures
Sahsen Ventures investment in Seed Round - A-Alpha Bio
AME Cloud Ventures
AME Cloud Ventures investment in Seed Round - A-Alpha Bio
Washington Research Foundation
Washington Research Foundation investment in Seed Round - A-Alpha Bio
Boom Capital
Boom Capital investment in Seed Round - A-Alpha Bio
Official Site Inspections
http://www.aalphabio.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "A-Alpha Bio"
About - A-Alpha Bio
A-Alpha Bio leverages synthetic biology and machine learning to measure, understand, and engineer protein-protein interactionsSee details»
A-Alpha Bio - Crunchbase Company Profile & Funding
A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.See details»
A-Alpha Bio Awarded Additional $14.5M from the …
May 21, 2024 Funding supports A-Alpha Bio’s continued partnership with Lawrence Livermore National Laboratory to generate large-scale antibody-antigen binding data and train computational models that ...See details»
A-Alpha Bio 2025 Company Profile: Valuation, Funding …
Sep 13, 2019 Information on valuation, funding, cap tables, investors, and executives for A-Alpha Bio. Use the PitchBook Platform to explore the full profile.See details»
A-Alpha Bio, Inc. | VentureRadar
Absci is the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform …See details»
A-Alpha Bio Inc. | Devex
Learn more about A-Alpha Bio Inc.'s jobs, projects, latest news, contact information and geographical presence. "Accelerating drug development with synthetic biology and next …See details»
A-Alpha Bio - app.biopharmiq.com
Description: A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental …See details»
A-Alpha Bio and LLNL expand collaboration with additional $2.4M …
May 17, 2023 <p>Almost exactly one year ago, we announced our first partnership with Lawrence Livermore National Laboratory (LLNL) to generate data and train machine learning …See details»
GitHub - A-Alpha-Bio/alphabind: AlphaBind code
AlphaBind code + model accompanying pre-print. Contribute to A-Alpha-Bio/alphabind development by creating an account on GitHub.See details»
A-Alpha Bio Awarded Additional $14.5M from the …
May 21, 2024 A-Alpha Bio Awarded Additional $14.5M from the Department of Defense to Accelerate Antibody Discovery and Optimization for Likely Biothreats Funding supports A-Alpha Bio’s continued partnership ...See details»
A-Alpha Bio Company Profile - Office Locations, Competitors
A-Alpha Bio has 5 employees at their 1 location and $3.03 m in total funding,. See insights on A-Alpha Bio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
AlphaBio, Inc.
AlphaBio provides innovative solutions to empower our partners in producing high-quality, cost-effective, and compliant pharmaceuticals and biotech products.See details»
A-Alpha Bio - Work in biotech
A-Alpha Bio is accelerating drug discovery by providing cell-based tools of protein interactions. Protein interactions govern all cellular processes and are therefore linked with disease. …See details»
Our Technology - A-Alpha Bio
Our AlphaSeq platform is the highest-throughput and most quantitative approach for measuring protein-protein bindingSee details»
A-Alpha Bio, a biotech startup that measures and predicts protein ...
Jul 25, 2023 The A-Alpha Bio team. The Seattle startup generates protein interaction data and partners with drug companies to help them find the best agents to test onSee details»
A-Alpha Bio Raises $22.4M in Series A2 to Scale Protein-Protein ...
SEATTLE, July 25, 2023 /PRNewswire-PRWeb/ — A-Alpha Bio, a synthetic biology and machine learning (ML) company that measures and engineers protein-protein interactions, today …See details»
A-Alpha Bio Awarded $800K to Develop Infectious Disease Drugs …
Jul 14, 2020 <p>SEATTLE, WA. – JULY 09, 2020 – A-Alpha Bio, a biotechnology startup that partners with pharmaceutical companies to accelerate drug development with …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
Predicting protein binding and engineering antibodies with …
Nov 12, 2024 Experimental approaches for quantitatively measuring protein-protein binding strength are notoriously low throughput—requiring recombinant protein expression and …See details»
Pipeline - A-Alpha Bio
A-Alpha Bio is advancing a differentiated pipeline of cis-targeting immunocytokines, consisting of a detuned and stabilized cytokine fused to a targeting antibody. Our strategy enables potent …See details»